Section of Forensic Chemistry, Department of Forensic Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
J Anal Toxicol. 2014 Jan-Feb;38(1):57-60. doi: 10.1093/jat/bkt096. Epub 2013 Dec 8.
Postmortem femoral blood concentrations of the antipsychotic drug risperidone and the active metabolite 9-hydroxyrisperidone were determined by an achiral LC-MS/MS method in 38 cases. The cause of death was classified as unrelated to risperidone in 30 cases, in which the sum of the concentration of the drug and metabolite ranged from below the limit of quantification to 0.058 mg/kg (median 0.0098 mg/kg). This concentration range, which largely corresponds to published in vivo plasmalevels under therapy, may serve as a reference for judgment of postmortem cases involving risperidone. In one case, risperidone was judged to be a contributing factor to death, and the sum of concentrations was 0.29 mg/kg. This concentration is of the same order of magnitude as observed for plasma levels in clinical intoxication cases. For the remaining seven cases, the cause of death was unclear. The measurements observed here do not suggest that risperidone is subject to major postmortem redistribution.
采用非手性 LC-MS/MS 方法在 38 例案例中测定了抗精神病药利培酮及其活性代谢物 9-羟基利培酮死后股骨血浓度。30 例案例中,死因被归类为与利培酮无关,药物和代谢物浓度之和从低于定量下限到 0.058mg/kg(中位数 0.0098mg/kg)。该浓度范围与治疗中发表的体内血浆水平大致相当,可作为涉及利培酮的死后案例判断的参考。在一个案例中,利培酮被判断为死亡的促成因素,浓度总和为 0.29mg/kg。该浓度与临床中毒案例中观察到的血浆水平处于同一数量级。对于其余七个案例,死因尚不清楚。这里观察到的测量结果并不表明利培酮会发生大量死后再分布。